Swift Biosciences Blog Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX

Fleur van der Sijde , Zakia Azmani, Marc G. Besselink, Bert A. Bonsing, Jan Willem B. de Groot, Bas Groot Koerkamp, Brigitte C. M. Haberkorn, Marjolein Y. V. Homs, Wilfred F. J. van IJcken , Quisette P. Janssen, Martijn P. Lolkema, Saskia A. C. Luelmo , Leonie J. M. Mekenkamp, Dana A. [...]